TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 27559840

Group type: EXPERIMENTAL
Intervention: Adapted-dose (AD) group: increase of ribavirin dose if D0AUC0‐4h <1755 mcg·h·L
Number of subjects: 221

Group type: COMPARATOR
Intervention: Fixed-dose (FD) group: standard of care with peginterferon‐α2a 180 mcg·wk and weight‐based ribavirin 1000‐1200 mg/d during 48 weeks
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Adapted-dose (AD) group
Number of subjects: 221

Group type: COMPARATOR
Intervention: Fixed-dose (FD) group
Number of subjects: 221
Study: 25041111

Group type: EXPERIMENTAL
Intervention: EpiPen
Number of subjects: 100

Group type: COMPARATOR
Intervention: Anapen
Number of subjects: 100
Study: 22909077

Group type: COMPARATOR
Intervention: Control group without pretreatment sutures (61 cases)
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Antibiotic/steroid-coated sutures (200 cases)
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Antiseptic-soaked and antibiotic/steroid-coated sutures (141 cases)
Number of subjects: 302
Study: 20606677

Group type: EXPERIMENTAL
Intervention: 1 gallon of polyethylene glycol (PEG) in the morning of the colonoscopy
Number of subjects: 136

Group type: COMPARATOR
Intervention: 1 gallon of polyethylene glycol (PEG) in the evening before the colonoscopy
Number of subjects: 136
Study: 20180666

Group type: EXPERIMENTAL
Intervention: Cocaine use diagnosis in PS group
Number of subjects: 515

Group type: EXPERIMENTAL
Intervention: Alcohol or opioid use diagnosis in PS group
Number of subjects: 515

Group type: EXPERIMENTAL
Intervention: Cocaine use diagnosis in MM group
Number of subjects: 515

Group type: EXPERIMENTAL
Intervention: Alcohol use diagnosis in MM group
Number of subjects: 515

Group type: EXPERIMENTAL
Intervention: Opiate use diagnosis in MM group
Number of subjects: 515

Group type: EXPERIMENTAL
Intervention: Substance using days in both samples
Number of subjects: 515
Study: 16130646

Group type: COMPARATOR
Intervention: Normal feet
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Flat feet
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Cavus feet
Number of subjects: 230
Study: 11906805

Group type: EXPERIMENTAL
Intervention: Intervention (street outreach, cognitive behavioral groups, individual counseling)
Number of subjects: 175

Group type: COMPARATOR
Intervention: Comparison group (no specific intervention mentioned)
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Intervention (attended 0-1 cognitive behavioral group sessions)
Number of subjects: 175
Study: 9914571

Group type: EXPERIMENTAL
Intervention: Danazol 200 mg daily during the luteal phase
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 7501348

Group type: EXPERIMENTAL
Intervention: Suction drains inserted along the pelvic sidewalls
Number of subjects: 100

Group type: COMPARATOR
Intervention: No drains inserted
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Suction drains
Number of subjects: 100

Group type: COMPARATOR
Intervention: No drains
Number of subjects: 100
Study: 2102130

Group type: EXPERIMENTAL
Intervention: Ketanserin (40-80 mg/day, oral therapy)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Ketanserin (20 mg, sublingual; 10 mg, intravenous)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Ketanserin
Number of subjects: 55

Group type: COMPARATOR
Intervention: Nifedipine (10 mg)
Number of subjects: 55
Study: 490345

Group type: EXPERIMENTAL
Intervention: Heat stimuli at three different maximal levels applied in randomized order, with 12 sec heat pulses starting from a base line temperature of 43.0-43.5 degrees C.
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Subject's ratings on a six-point scale from 'just noticeable' to 'very hot, painful'.
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Integrated spike discharges from the C fibres.
Number of subjects: 8
Study: 30579447

Group type: EXPERIMENTAL
Intervention: Low-fidelity simulation training with tablet-paired physical endovascular tool navigation (group S)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional learning through a video podcast (group V)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Low-fidelity simulation training with tablet-paired touch-gesture navigation (group A)
Number of subjects: 50
Study: 28768251

Group type: EXPERIMENTAL
Intervention: Acupressure
Number of subjects: 119

Group type: COMPARATOR
Intervention: Sham
Number of subjects: 119

Group type: COMPARATOR
Intervention: Usual-care
Number of subjects: 119
Study: 25652112

Group type: EXPERIMENTAL
Intervention: Stem cells delivered onto a β‐tricalcium phosphate scaffold
Number of subjects: 30

Group type: COMPARATOR
Intervention: Scaffold alone
Number of subjects: 30
Study: 22556207

Group type: EXPERIMENTAL
Intervention: Whole-body hypothermia
Number of subjects: 58

Group type: COMPARATOR
Intervention: Normothermia (control group)
Number of subjects: 58
Study: 21733417

Group type: EXPERIMENTAL
Intervention: Diclofenac 75 mg orally twice per day for 10 days
Number of subjects: 90

Group type: COMPARATOR
Intervention: Paracetamol 500 mg orally three times per day for 10 days
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 90
Study: 19459518

Group type: EXPERIMENTAL
Intervention: Lower uterine compression
Number of subjects: 64

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 64
Study: 16843633

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard care control
Number of subjects: 60
Study: 15319045

Group type: EXPERIMENTAL
Intervention: Home-care telemedicine
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Reasons for refusal
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Eligibility criteria
Number of subjects: 302
Study: 11843761

Group type: EXPERIMENTAL
Intervention: Low-flux group (dialyzer F6, low-flux polysuphone)
Number of subjects: 72

Group type: COMPARATOR
Intervention: High-flux group (dialyzer Filtral 12, sulphonated high-flux polyacrylonitrile)
Number of subjects: 72
Study: 9509447

Group type: EXPERIMENTAL
Intervention: OL HDF
Number of subjects: 13
Study: 7982769

Group type: EXPERIMENTAL
Intervention: Oral theophylline (levels 9.5 +/- 1 mg/l)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 2908286

Group type: EXPERIMENTAL
Intervention: Permethrin-treated bed nets
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo-treated nets
Number of subjects: 0
Study: 15848545

Group type: EXPERIMENTAL
Intervention: sirolimus (SRL) + cyclosporine (CsA)
Number of subjects: 81
Study: 31990581

Group type: EXPERIMENTAL
Intervention: Collagen peptide (CP) supplementation (10 g/day for 12 weeks)
Number of subjects: 167

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 167
Study: 31547517

Group type: EXPERIMENTAL
Intervention: NAS advertising condition
Number of subjects: 1128

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1128
Study: 27598707

Group type: EXPERIMENTAL
Intervention: 8-week magazine-based discussion group program, Fit Minded College Edition, with education on physical activity, self-worth, and nutrition.
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group received magazines but did not attend meetings or access the website.
Number of subjects: 37
Study: 26632698

Group type: EXPERIMENTAL
Intervention: Modified mini-surgical percutaneous dilatational tracheostomy (msPDT)
Number of subjects: 360

Group type: COMPARATOR
Intervention: Surgical tracheostomy (ST)
Number of subjects: 360
Study: 23768465

Group type: EXPERIMENTAL
Intervention: Anthracycline chemotherapy
Number of subjects: 39
Study: 21219598

Group type: EXPERIMENTAL
Intervention: Rapid genetic counseling and testing (RGCT)
Number of subjects: 255

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 255
Study: 19901877

Group type: EXPERIMENTAL
Intervention: Two-layer compression system
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Short-stretch compression system
Number of subjects: 24

Group type: COMPARATOR
Intervention: Four-layer compression system
Number of subjects: 24
Study: 16777690

Group type: EXPERIMENTAL
Intervention: Irinotecan (130 mg/m2 IV over 90 minutes) and Docetaxel (50 mg/m2 IV over 60 minutes) on Day 1 q3 weeks for 6 cycles
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Irinotecan and Docetaxel
Number of subjects: 46
Study: 15577128

Group type: EXPERIMENTAL
Intervention: Raloxifene at a dosage of 60 or 120 mg/day for 3 years
Number of subjects: 7705

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7705
Study: 10989959

Group type: COMPARATOR
Intervention: 4 mg 17beta-estradiol valerate (E2)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 9288377

Group type: EXPERIMENTAL
Intervention: Midazolam-flumazenil
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 8245345

Group type: EXPERIMENTAL
Intervention: Group A - second balloon inflation at a higher level than the first
Number of subjects: 48

Group type: COMPARATOR
Intervention: Group B - first two inflations at the same level of balloon pressure
Number of subjects: 48
Study: 3828253

Group type: EXPERIMENTAL
Intervention: Continuous oestrogen-norethisterone acetate
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 31421989

Group type: EXPERIMENTAL
Intervention: HDM SLIT tablets for 4 weeks followed by dual therapy with JCP SLIT tablets for 8 weeks
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: JCP SLIT tablets for 4 weeks followed by dual therapy with HDM SLIT tablets for 8 weeks
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Dual therapy with both SLIT tablets administered within 5 min after 4 weeks of monotherapy
Number of subjects: 109
Study: 29788827

Group type: EXPERIMENTAL
Intervention: Video-based education
Number of subjects: 225

Group type: COMPARATOR
Intervention: Nurse-led education
Number of subjects: 225
Study: 28330808

Group type: EXPERIMENTAL
Intervention: Sunitinib (4-weeks-on/2-weeks-off schedule)
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Sunitinib (continuous daily dosing schedule)
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Sunitinib (all patients)
Number of subjects: 202
Study: 25660590

Group type: EXPERIMENTAL
Intervention: Nd:YAG laser (G1)
Number of subjects: 163

Group type: COMPARATOR
Intervention: QMR scalpel (G2)
Number of subjects: 163

Group type: COMPARATOR
Intervention: Cold blade (G3)
Number of subjects: 163
Study: 23357837

Group type: EXPERIMENTAL
Intervention: 100-mg pregabalin capsule
Number of subjects: 12

Group type: COMPARATOR
Intervention: 100-mg pregabalin solution (capsule dissolved in water)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Comparison of both interventions
Number of subjects: 12
Study: 21192149

Group type: EXPERIMENTAL
Intervention: Rimonabant (20 mg/d)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 18629368

Group type: EXPERIMENTAL
Intervention: Fixed-dose combination strategy (perindopril/indapamide 2 mg/0.625 mg, with possible increase to 3 mg/0.935 mg, and 4 mg/1.250 mg if needed)
Number of subjects: 329

Group type: EXPERIMENTAL
Intervention: Sequential monotherapy approach (atenolol 50 mg, followed by losartan 50 mg and amlodipine 5 mg if needed)
Number of subjects: 329

Group type: EXPERIMENTAL
Intervention: Stepped-care strategy (valsartan 40 mg, followed by valsartan 80 mg and valsartan 80 mg + hydrochlorothiazide 12.5 mg if needed)
Number of subjects: 329
Study: 16613215

Group type: EXPERIMENTAL
Intervention: Probucol (500 mg/day)
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: Pravastatin (10 mg/day)
Number of subjects: 246

Group type: COMPARATOR
Intervention: Diet alone (Control)
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: Lipid-lowering therapy (including probucol and pravastatin)
Number of subjects: 246
Study: 12621389

Group type: EXPERIMENTAL
Intervention: Telithromycin (800 mg daily, repeated doses)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Telithromycin (800 mg, single dose)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Telithromycin (1600 mg, single dose)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Telithromycin (2400 mg, single dose)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 10562690

Group type: EXPERIMENTAL
Intervention: Sucralfate
Number of subjects: 102

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Chemotherapy
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: BID fractionation
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Poor KPS
Number of subjects: 102
Study: 8692511

Group type: EXPERIMENTAL
Intervention: Burch procedure
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Sling procedure
Number of subjects: 77

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 77
Study: 1768158

Group type: EXPERIMENTAL
Intervention: Folinic acid
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 6890700

Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Phenobarbital
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Switch from placebo to active medication
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Task-dependent changes
Number of subjects: 15
Study: 31773873

Group type: EXPERIMENTAL
Intervention: Counselor-initiated (CI) adaptation of the Look AHEAD intensive lifestyle intervention
Number of subjects: 248

Group type: COMPARATOR
Intervention: Self-paced (SP) adaptation
Number of subjects: 248
Study: 30764769

Group type: EXPERIMENTAL
Intervention: Antibiotic treatment for 7 days
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Antibiotic treatment for 14 days
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Procalcitonin (PCT)
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Mid-regional proadrenomedullin (MR-proADM)
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: C-reactive protein (CRP)
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: PCT concentrations
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: MR-proADM levels
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: CRP
Number of subjects: 249
Study: 29717175

Group type: EXPERIMENTAL
Intervention: Ginger capsules
Number of subjects: 178

Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 178
Study: 26983390

Group type: EXPERIMENTAL
Intervention: UC-MSC treatment (0.5-1.0×10(6) cells/kg/month for 3 months)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Standard medical treatment only (control group)
Number of subjects: 180
Study: 24513025

Group type: EXPERIMENTAL
Intervention: Methylphenidate (30 mg)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Atomoxetine (60 mg)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Citalopram (30 mg)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 22951360

Group type: EXPERIMENTAL
Intervention: Cycling intervention
Number of subjects: 37
Study: 20853930

Group type: EXPERIMENTAL
Intervention: Practicing small acts of self-control for 2 weeks before quitting smoking
Number of subjects: 122

Group type: COMPARATOR
Intervention: Practicing a task that increased awareness of self-control or feelings of confidence
Number of subjects: 122
Study: 17492904

Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Atorvastatin
Number of subjects: 0
Study: 11008278

Group type: EXPERIMENTAL
Intervention: Balneophysical treatments (process expectation)
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Vocational counselling (process expectation)
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Reduction of complaints (outcome expectation)
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Ability for work (outcome expectation)
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Overall expectations
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Functional status correlation
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Emotional distress correlation
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Locus of control correlation
Number of subjects: 248
Study: 9182387

Group type: EXPERIMENTAL
Intervention: Budesonide 800 micrograms/day
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate 800 micrograms/day
Number of subjects: 13
Study: 8456526

Group type: EXPERIMENTAL
Intervention: Color Doppler imaging (CDI) and angiography in hypertensive cases
Number of subjects: 60

Group type: COMPARATOR
Intervention: Color Doppler imaging (CDI) and angiography in normotensive cases
Number of subjects: 60
Study: 3510687

Group type: EXPERIMENTAL
Intervention: Nefopam
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 28285432

Group type: EXPERIMENTAL
Intervention: Bovine colostrum (BC) 3.2 g/day
Number of subjects: 18

Group type: COMPARATOR
Intervention: Whey protein (WP) 3.2 g/day
Number of subjects: 18
Study: 27452603

Group type: EXPERIMENTAL
Intervention: Lifestyle-induced weight loss program (supervision via telemonitoring)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 74
Study: 24742126

Group type: EXPERIMENTAL
Intervention: Pole walking program (Exerstrider method), 12 weeks, 3 sessions per week, building from 20 to 30 minutes
Number of subjects: 60

Group type: COMPARATOR
Intervention: Walking program, 12 weeks, 3 sessions per week, building from 20 to 30 minutes
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Pole walking program
Number of subjects: 60

Group type: COMPARATOR
Intervention: Walking program
Number of subjects: 60
Study: 23613788

Group type: EXPERIMENTAL
Intervention: Dried Blood Spot (DBS) sampling for HBsAg detection
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Dried Blood Spot (DBS) sampling for anti-HBs detection
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Dried Blood Spot (DBS) sampling for HBV DNA detection
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Dried Blood Spot (DBS) sampling for HBeAg detection
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Dried Blood Spot (DBS) sampling for HBV genotyping and mutation detection
Number of subjects: 200
Study: 19949417

Group type: EXPERIMENTAL
Intervention: Stepwise protocol for bowel management (BM)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 68
Study: 19065892

Group type: EXPERIMENTAL
Intervention: PTS (Protoparaxotril Saporlirs)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: PTS plus Aspirin
Number of subjects: 140

Group type: COMPARATOR
Intervention: Control group D (no aspirin)
Number of subjects: 140
Study: 16469469

Group type: EXPERIMENTAL
Intervention: Standard education and additional computer-based education (n=82)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Standard education (n=72)
Number of subjects: 154
Study: 12477757

Group type: EXPERIMENTAL
Intervention: Omeprazole 40 mg twice daily + Amoxicillin 1 g twice daily
Number of subjects: 181

Group type: COMPARATOR
Intervention: Omeprazole 20 mg once daily
Number of subjects: 181
Study: 10923593

Group type: EXPERIMENTAL
Intervention: Phenylbutazone
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: Metamizole
Number of subjects: 1

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1
Study: 8829556

Group type: EXPERIMENTAL
Intervention: Indomethacin 0.4 mg/kg bolus followed by continuous infusion 0.4 mg/kg/h
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Indomethacin 0.1, 0.2, and 0.3 mg/kg bolus followed by continuous infusion of 0.1, 0.2, and 0.3 mg/kg/h
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rectal application of 100 mg indomethacin
Number of subjects: 0
Study: 1520111

Group type: EXPERIMENTAL
Intervention: Molteno group
Number of subjects: 40

Group type: COMPARATOR
Intervention: ACTSEB group
Number of subjects: 40
Study: 29053981

Group type: EXPERIMENTAL
Intervention: Bright Light Therapy (BLT)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Dim Red Light Therapy (dRLT)
Number of subjects: 74
Study: 29927211

Group type: EXPERIMENTAL
Intervention: Pursed-lips breathing exercise (PBE)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Diaphragmatic breathing exercise (DBE)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 54
Study: 24555508

Group type: EXPERIMENTAL
Intervention: Priority setting with patient involvement
Number of subjects: 172

Group type: COMPARATOR
Intervention: No patient involvement
Number of subjects: 172
Study: 22310655

Group type: EXPERIMENTAL
Intervention: Functional exercise for deep cervical flexor training, performed for two weeks.
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned).
Number of subjects: 20
Study: 20149361

Group type: EXPERIMENTAL
Intervention: GnRH antagonist ganirelix
Number of subjects: 0
Study: 19145731

Group type: EXPERIMENTAL
Intervention: IFN-beta-1a 44 microg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IFN-beta-1a 66 microg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 15923802

Group type: EXPERIMENTAL
Intervention: Tandem transplants (T)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Single high-dose chemotherapy (S)
Number of subjects: 60
Study: 12791629

Group type: EXPERIMENTAL
Intervention: Dried formula milk intake in infancy (measured in oz)
Number of subjects: 679
Study: 10988090

Group type: EXPERIMENTAL
Intervention: Continuous tracheal gas insufflation (CTGI)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Non-CTGI
Number of subjects: 34
Study: 8871021

Group type: EXPERIMENTAL
Intervention: Class II amalgam restorations
Number of subjects: 1213
Study: 1514556

Group type: EXPERIMENTAL
Intervention: Meconium aspirator at -150 mm Hg with continuous suction
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Meconium aspirator at -80 mm Hg with continuous suction
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Meconium aspirator at -40 mm Hg with continuous suction
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 10F suction catheter at -150 mm Hg with continuous suction
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 10F suction catheter at -80 mm Hg with continuous suction
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 10F suction catheter at -40 mm Hg with continuous suction
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Hand pump with one activation
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Hand pump with two activations
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Continuous suction
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Increasing suction pressure
Number of subjects: 14